Apr 16, 2026
Abbott Laboratories (ABT) Q1 2026 Results: Revenue Surpasses Expectations on Cancer Diagnostics Strength
Abbott (ABT) Q1 2026 earnings beat revenue estimates at $11.16B. EPS at $1.15. Exact Sciences acquisition and medical devices fuel results.
The post Abbott Laboratories (ABT) Q1 2026 Results: Revenue Surpasses Expectations on Cancer Diagnostics Strength appeared first on Blockonomi.
Source: Blockonomi →Related News
- 45 minutes ago
GE Aerospace (GE) Stock Down 23%: Why Wall Street Sees a Golden Entry Point
- 51 minutes ago
Tony Robbins Reveals His Bold AI Investment Strategy: From Power Plants to Anthr...
- 58 minutes ago
Stock Futures Gain as Iran Diplomacy Advances and Crude Oil Retreats
- 1 hour ago
Himax Technologies (HIMX) Stock Soars 28% on Robust Q1 Results and Optimistic Q2...
- 1 hour ago
Apple (AAPL) Stock Reaches All-Time High Before Critical WWDC Event in June